SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-23-000087
Filing Date
2023-02-10
Accepted
2023-02-10 17:16:25
Documents
68
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q bivi-20221231_10q.htm   iXBRL 10-Q 1204951
2 EXHIBIT 10.1 bivi-20221231_10qex10z1.htm EX-10.1 18973
3 EXHIBIT 31.1 bivi-20221231_10qex31z1.htm EX-31.1 12099
4 EXHIBIT 31.2 bivi-20221231_10qex31z2.htm EX-31.2 12264
5 EXHIBIT 32.1 bivi-20221231_10qex32z1.htm EX-32.1 5289
6 EXHIBIT 32.2 bivi-20221231_10qex32z2.htm EX-32.2 5141
  Complete submission text file 0001520138-23-000087.txt   5396322

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bivi-20221231.xsd EX-101.SCH 43294
8 XBRL CALCULATION FILE bivi-20221231_cal.xml EX-101.CAL 44471
9 XBRL DEFINITION FILE bivi-20221231_def.xml EX-101.DEF 138233
10 XBRL LABEL FILE bivi-20221231_lab.xml EX-101.LAB 290048
11 XBRL PRESENTATION FILE bivi-20221231_pre.xml EX-101.PRE 242825
62 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20221231_10q_htm.xml XML 949541
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 23613417
SIC: 2834 Pharmaceutical Preparations